Search
for
Sort by
Research 211–240 of 1000+
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Diseases of the Canine Prostate Gland
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- Steroidogenesis in steroid related cancers
- Reply to: a rare case of vulvar skin metastasis of rectal cancer after operation
- Incidence of alopecia from endocrine therapies in cancer
- S89 Clinical outcomes of high risk prostate adenocarcinoma (T3 and Gleason score ≥8)
- Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata
- Urological Oncology: Testis Cancer and Advances in Oncological Therapy
- 409 ANDROGEN RECEPTOR GENE POLYMORPHISM (SNP RS6152) – ITS RELATIONSHIP TO ANDROGEN-SENSITIVE GENES EXPRESSION IN BENIGN PROSTATIC HYPERPLASIA, CARCINOMA OF THE PROSTATE AND ANDROGENETIC ALOPECIA
- NEURONAL MIMICRY AS A RESISTANCE PHENOTYPE IN CANCER CELLS
- Male alopecia, finasteride, and cancer risk
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Is dehydroepiandrosterone a hormone?
- Molecular basis of androgen insensitivity
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Structure of human type II 5 alpha-reductase gene.
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- 9 Role of 5α-reductase in health and disease
- Pharmacology of antiandrogens
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- Selenium or No Selenium- That Is the Question in Tumor Patients: A New Controversy
- Significance of the polyglutamine tract polymorphism in the androgen receptor
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- BIOLOGICAL ACTIVITY OF ANTIANDROGENS
- Selective non-steroidal inhibitors of 5α-reductase type 1
- 5α-Reduced glucocorticoids: a story of natural selection
- Cardiovascular Toxicities of Androgen Deprivation Therapy